Developer docs
API playgroundTry for free, no card

Search company profiles

Mindable Health

Full company profile

uuid0009yod

Namestring
Mindable Health
Legal namestring
Mindable Health GmbH
Websiteurl
mindable.health
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Mindable Health GmbH is a Berlin-based digital health company founded in 2018 that develops CE-marked prescription mobile applications for the treatment of anxiety disorders. The company's product portfolio consists of two core apps: Mindable: Panic & Agoraphobia (PZN 17454202, ICD-10 F40.0 and F41.0) and Mindable: Social Phobia (PZN 19166938, ICD-10 F40.1). Both applications deliver structured cognitive behavioral therapy-based interventions including guided exercises, journaling functionality, real-time exposure level tracking, and for the social phobia app, a structured 12-week attention training program. The applications are classified as medical devices and were developed in cooperation with licensed psychotherapists.

The underlying technology is a regulated digital health platform certified to ISO 13485 (Quality Management) and ISO 27001 (Information Security) by TÜV, with servers hosted in Germany to meet stringent data protection requirements. Mindable operates a B2B2C distribution model: patients complete a diagnostic questionnaire and receive a prescription from a healthcare provider, after which the apps are reimbursed by all statutory health insurance providers in Germany and provided free of charge to patients. The company is co-founded by Linda Weber (CEO) and Eddie Rietz (CTO), and operates with a headcount of 11-50 employees. Clinical outcomes reported include 91% user recommendation rates for the Panic & Agoraphobia app and a 1-in-8 symptom-free rate after 8 weeks of use.

Revenue mechanics are tied entirely to the German DiGA-style reimbursement pathway, with no disclosed private payer, employer-sponsored, or out-of-pocket revenue streams. Marketing relies on content marketing (blog), self-diagnostic online tools, App Store presence, and dedicated clinician engagement resources. The company was an early participant in the Startupbootcamp Digital Health Berlin accelerator in 2018 and currently operates exclusively in Germany with no disclosed international expansion.

Short descriptiontext

Mindable Health GmbH is a Berlin-based digital therapeutics company that develops CE-marked prescription mobile apps for treating panic disorder, agoraphobia, and social phobia, distributed via the German statutory health insurance reimbursement system to patients referred by licensed clinicians.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBerlin, Germany
HQ citystring
Berlin
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital therapeutics, anxiety treatment apps, prescription medical devices, cognitive behavioral therapy, mental health software
Industry2 codes
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLALAEAA
General Mental Health Therapy Platforms (Talk Therapy)
Healthcare & Life Sciences/Telehealth Platforms/Behavioral & Mental Health Teletherapy Platforms
NAICS code1 code
  • Health Care and Social Assistance62
SIC code2 codes
  • Services-Misc Health & Allied Services, Nec8090
  • Services-Health Services8000
Product category
Digital Therapeutics
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Statutory Health Insurance Reimbursement
TypeSubscription Recurring
Description

Mindable apps are provided free of charge to patients via reimbursement from statutory health insurance providers in Germany. Healthcare providers prescribe the apps (PZN codes listed), and costs are covered through the German healthcare system.

mindable.health:443
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
Pricing details1 tier
1Patient Access (Prescription-based)
ModelSubscriptionBilling cadenceAnnual
Notes

Free of charge on prescription. Reimbursed by all statutory health insurance providers. Users access the app after receiving a prescription through the diagnostic questionnaire pathway.

mindable.health:443
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1Mindable: Panic & Agoraphobia
Description

App for treating panic disorder and agoraphobia with PZN 17454202, F40.0/F41.0 classification.

mindable.health:443
+1 more record
Core offering1 text field

Mindable Health develops and sells CE-marked prescription mobile medical device applications that deliver structured cognitive behavioral therapy for anxiety disorders. Its two flagship apps—Mindable: Panic & Agoraphobia (PZN 17454202, ICD-10 F40.0/F41.0) and Mindable: Social Phobia (PZN 19166938, ICD-10 F40.1)—are prescribed by healthcare providers and reimbursed by all statutory health insurance providers in Germany.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 91% of users would recommend the Mindable: Panic & Agoraphobia program
+3 more records
Product overview1 text field

Mindable Health offers two distinct mobile medical device applications designed to treat anxiety-related disorders. Mindable: Panic & Agoraphobia addresses panic disorder and agoraphobia (F40.0, F41.0), while Mindable: Social Phobia targets social anxiety disorder (F40.1). Both apps provide cognitive behavioral therapy-based interventions including guided exercises, journaling, exposure tracking, and educational content. The apps are prescribed by healthcare providers and are reimbursed by all statutory health insurance providers in Germany.

Product and service1 record
1Mindable: Panic & Agoraphobia
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

GAIA is a leading German digital therapeutics company specializing in evidence-based DTx for mental health conditions including depression, anxiety, and insomnia. Like Mindable, GAIA's products are CE-marked and reimbursed through the German DiGA pathway, making it the closest direct competitor in the prescription DTx model.

TypeDirect peer
Description

HelloBetter (formerly GET.ON) is a German digital therapeutics company offering CE-marked, DiGA-reimbursed online courses for depression, stress, and chronic conditions. It operates the same prescription-based B2B2C model as Mindable through German statutory health insurance reimbursement.

TypeDirect peer
Description

Selfapy is a Berlin-based digital therapeutics company offering DiGA-listed online therapy programs for depression, burnout, and anxiety. It directly competes with Mindable in the same prescription digital therapeutics channel targeting German statutory health insurers.

4Deprexis (now part of GAIA)
TypeDirect peer
Description

Deprexis is an evidence-based digital therapeutic for depression that was among the first DiGA-approved apps in Germany. It shares Mindable's prescription-based CBT delivery model and reimbursement pathway through German statutory health insurers.

5Moodpath
TypeDirect peer
Description

Moodpath is a German-developed mental health app offering screening and psychoeducational modules for depression and anxiety. While its reimbursement status differs, it competes for the same anxious patient population and clinician prescribing relationships in Germany.

TypeBroad incumbent
Description

Headspace Health (combining Headspace and Ginger) is a global mental health and wellness platform offering meditation, coaching, and therapy. It overlaps with Mindable's anxiety use cases at the consumer end and increasingly pursues B2B payer partnerships that mirror the German DiGA reimbursement model.

7Calm
TypeBroad incumbent
Description

Calm is a global consumer mental wellness brand offering meditation and sleep apps. It addresses the same anxious end-user population as Mindable through direct-to-consumer and employer channels, though it lacks Mindable's prescription medical-device positioning.

TypeDirect peer
Description

Akili Interactive is a prescription digital therapeutics company that develops FDA-cleared cognitive treatment apps. It shares Mindable's regulatory pathway (FDA/CE cleared prescription DTx), though its indications (ADHD) differ from Mindable's anxiety focus.

TypeEmerging player
Description

Woebot Health develops AI-driven conversational mental health tools for anxiety and depression management. It overlaps with Mindable's anxiety therapeutic area through a different delivery modality (chatbot vs. structured CBT program) and serves similar enterprise/payer customers.

TypeDirect peer
Description

Sympatient is a German digital health company offering VR-based exposure therapy for anxiety disorders. It targets the same anxiety patient population and clinician prescribers in Germany, using a complementary VR modality to Mindable's mobile CBT approach.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mindable Health

Digital Therapeuticsmindable.health

Mindable Health GmbH is a Berlin-based digital therapeutics company that develops CE-marked prescription mobile apps for treating panic disorder, agoraphobia, and social phobia, distributed via the German statutory health insurance reimbursement system to patients referred by licensed clinicians.

What Mindable Health does

Mindable Health GmbH is a Berlin-based digital health company founded in 2018 that develops CE-marked prescription mobile applications for the treatment of anxiety disorders. The company's product portfolio consists of two core apps: Mindable: Panic & Agoraphobia (PZN 17454202, ICD-10 F40.0 and F41.0) and Mindable: Social Phobia (PZN 19166938, ICD-10 F40.1). Both applications deliver structured cognitive behavioral therapy-based interventions including guided exercises, journaling functionality, real-time exposure level tracking, and for the social phobia app, a structured 12-week attention training program. The applications are classified as medical devices and were developed in cooperation with licensed psychotherapists.

The underlying technology is a regulated digital health platform certified to ISO 13485 (Quality Management) and ISO 27001 (Information Security) by TÜV, with servers hosted in Germany to meet stringent data protection requirements. Mindable operates a B2B2C distribution model: patients complete a diagnostic questionnaire and receive a prescription from a healthcare provider, after which the apps are reimbursed by all statutory health insurance providers in Germany and provided free of charge to patients. The company is co-founded by Linda Weber (CEO) and Eddie Rietz (CTO), and operates with a headcount of 11-50 employees. Clinical outcomes reported include 91% user recommendation rates for the Panic & Agoraphobia app and a 1-in-8 symptom-free rate after 8 weeks of use.

Revenue mechanics are tied entirely to the German DiGA-style reimbursement pathway, with no disclosed private payer, employer-sponsored, or out-of-pocket revenue streams. Marketing relies on content marketing (blog), self-diagnostic online tools, App Store presence, and dedicated clinician engagement resources. The company was an early participant in the Startupbootcamp Digital Health Berlin accelerator in 2018 and currently operates exclusively in Germany with no disclosed international expansion.

Mindable Health firmographics

Firmographics
Name
Mindable Health
Legal name
Mindable Health GmbH
Website
https://mindable.health
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
Mindable Health GmbH is a Berlin-based digital therapeutics company that develops CE-marked prescription mobile apps for treating panic disorder, agoraphobia, and social phobia, distributed via the German statutory health insurance reimbursement system to patients referred by licensed clinicians.
Ownership category
akta.pro rank

Mindable Health industry classification

Industry
Product category
Digital Therapeutics
NAICS
Health Care and Social Assistance (62)
SIC
Services-Misc Health & Allied Services, Nec (8090), Services-Health Services (8000)
akta.pro industry
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLALAEAA
General Mental Health Therapy Platforms (Talk Therapy)
Healthcare & Life Sciences/Telehealth Platforms/Behavioral & Mental Health Teletherapy Platforms

Keywords

  • Digital therapeutics
  • Anxiety treatment apps
  • Prescription medical devices
  • Cognitive behavioral therapy
  • Mental health software

Where Mindable Health is headquartered

Location

Headquarters

HQ city
Berlin
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Mindable Health business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Statutory Health Insurance Reimbursement: Mindable apps are provided free of charge to patients via reimbursement from statutory health insurance providers in Germany. Healthcare providers prescribe the apps (PZN codes listed), and costs are covered through the German healthcare system.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualPatient Access (Prescription-based)

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Mindable Health product offering

Product offering

Core offering

Mindable Health develops and sells CE-marked prescription mobile medical device applications that deliver structured cognitive behavioral therapy for anxiety disorders. Its two flagship apps—Mindable: Panic & Agoraphobia (PZN 17454202, ICD-10 F40.0/F41.0) and Mindable: Social Phobia (PZN 19166938, ICD-10 F40.1)—are prescribed by healthcare providers and reimbursed by all statutory health insurance providers in Germany.

Product overview

Mindable Health offers two distinct mobile medical device applications designed to treat anxiety-related disorders. Mindable: Panic & Agoraphobia addresses panic disorder and agoraphobia (F40.0, F41.0), while Mindable: Social Phobia targets social anxiety disorder (F40.1). Both apps provide cognitive behavioral therapy-based interventions including guided exercises, journaling, exposure tracking, and educational content. The apps are prescribed by healthcare providers and are reimbursed by all statutory health insurance providers in Germany.

Differentiator

Problem solved

Functional benefit

Brands

  • Mindable: Panic & Agoraphobia: App for treating panic disorder and agoraphobia with PZN 17454202, F40.0/F41.0 classification.
  • Mindable: Social Phobia

Products and services

  • Mindable: Panic & Agoraphobia

Quantifiable outcome

  • 91% of users would recommend the Mindable: Panic & Agoraphobia program
  • +3 more outcomes

Companies that use Mindable Health

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles4 records

Mindable Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Mindable Health partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Mindable Health competitors and assessment

Company assessment

Direct peers

  • GAIA AG: GAIA is a leading German digital therapeutics company specializing in evidence-based DTx for mental health conditions including depression, anxiety, and insomnia. Like Mindable, GAIA's products are CE-marked and reimbursed through the German DiGA pathway, making it the closest direct competitor in the prescription DTx model.
  • HelloBetter: HelloBetter (formerly GET.ON) is a German digital therapeutics company offering CE-marked, DiGA-reimbursed online courses for depression, stress, and chronic conditions. It operates the same prescription-based B2B2C model as Mindable through German statutory health insurance reimbursement.
  • Selfapy: Selfapy is a Berlin-based digital therapeutics company offering DiGA-listed online therapy programs for depression, burnout, and anxiety. It directly competes with Mindable in the same prescription digital therapeutics channel targeting German statutory health insurers.
  • Deprexis (now part of GAIA): Deprexis is an evidence-based digital therapeutic for depression that was among the first DiGA-approved apps in Germany. It shares Mindable's prescription-based CBT delivery model and reimbursement pathway through German statutory health insurers.
  • Moodpath: Moodpath is a German-developed mental health app offering screening and psychoeducational modules for depression and anxiety. While its reimbursement status differs, it competes for the same anxious patient population and clinician prescribing relationships in Germany.
  • Akili Interactive: Akili Interactive is a prescription digital therapeutics company that develops FDA-cleared cognitive treatment apps. It shares Mindable's regulatory pathway (FDA/CE cleared prescription DTx), though its indications (ADHD) differ from Mindable's anxiety focus.
  • Sympatient: Sympatient is a German digital health company offering VR-based exposure therapy for anxiety disorders. It targets the same anxiety patient population and clinician prescribers in Germany, using a complementary VR modality to Mindable's mobile CBT approach.

Broad incumbents

  • Headspace Health: Headspace Health (combining Headspace and Ginger) is a global mental health and wellness platform offering meditation, coaching, and therapy. It overlaps with Mindable's anxiety use cases at the consumer end and increasingly pursues B2B payer partnerships that mirror the German DiGA reimbursement model.
  • Calm: Calm is a global consumer mental wellness brand offering meditation and sleep apps. It addresses the same anxious end-user population as Mindable through direct-to-consumer and employer channels, though it lacks Mindable's prescription medical-device positioning.

Emerging players

  • Woebot Health: Woebot Health develops AI-driven conversational mental health tools for anxiety and depression management. It overlaps with Mindable's anxiety therapeutic area through a different delivery modality (chatbot vs. structured CBT program) and serves similar enterprise/payer customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Mindable Health social profiles

Digital presence

Mindable Health compliance and trust

Trust signal

Compliance2 records

Mindable Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mindable Health leadership team

Management profile

Number of profiles

Profiles2 records

Mindable Health funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mindable Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mindable Health

What does Mindable Health do?

Mindable Health develops and sells CE-marked prescription mobile medical device applications that deliver structured cognitive behavioral therapy for anxiety disorders. Its two flagship apps—Mindable: Panic & Agoraphobia (PZN 17454202, ICD-10 F40.0/F41.0) and Mindable: Social Phobia (PZN 19166938, ICD-10 F40.1)—are prescribed by healthcare providers and reimbursed by all statutory health insurance providers in Germany.

Is Mindable Health a public or private company?

Mindable Health is a private company. It is classified as venture growth investor backed and is currently operating.

When was Mindable Health founded?

Mindable Health was founded in 2019. It employs 11 to 50 people.

Where is Mindable Health based?

Mindable Health is headquartered in Berlin, Germany, in the Europe region.

How does Mindable Health make money?

One revenue line is on record: statutory Health Insurance Reimbursement.

Who are Mindable Health's main competitors?

Direct peers on record are GAIA AG, HelloBetter, Selfapy, Deprexis (now part of GAIA), Moodpath, Akili Interactive and Sympatient. Broad incumbents are Headspace Health and Calm. Woebot Health is listed as an emerging player.

Does Mindable Health have an API?

No public API is recorded for Mindable Health.

What industry is Mindable Health in?

Mindable Health's product category is Digital Therapeutics. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital), with a secondary code of HLALAEAA, General Mental Health Therapy Platforms (Talk Therapy). Its NAICS code is 62 and its SIC code is 8090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales